Skip to content

Clinical trials

Completed Muscular Dystrophy, Duchenne trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Status: Completed Country / region: United Kingdom Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20091
20102
20122
20133
20154
20165
20174
20184
20201
20213
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sarepta Therapeutics, Inc.5
PTC Therapeutics4
ReveraGen BioPharma, Inc.4
Great Ormond Street Hospital for Children NHS Foundation Trust2
Novartis Pharmaceuticals2
Summit Therapeutics2
Catabasis Pharmaceuticals1
Edgewise Therapeutics, Inc.1
EspeRare Foundation1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne34
Muscular Dystrophies6
Neuromuscular Diseases3
Musculoskeletal Diseases2
Osteoporosis2
Autistic Disorder1
Genetic Diseases, Inborn1
Genetic Diseases, X-Linked1
Muscular Diseases1
Muscular Disorders, Atrophic1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.